A Multiple Antigen Lipophilic Adjuvant Carrier (MALAC) System
Funder
National Health and Medical Research Council
Funding Amount
$141,500.00
Summary
We have developed a Multiple-Antigen-Lipophilic-Adjuvant-Carrier (MALAC) system, based on the incorporation of lipoamino acids into a poly-functional core that provides an excellent means for enhancing the antigenicity of a potential peptide vaccine. A system is used for generating antibodies without the use of any conventional adjuvant. The system comprises two or more different antigens and one or more lipid anchor. The key of this system is a novel carrier construct, which is non-toxic and no ....We have developed a Multiple-Antigen-Lipophilic-Adjuvant-Carrier (MALAC) system, based on the incorporation of lipoamino acids into a poly-functional core that provides an excellent means for enhancing the antigenicity of a potential peptide vaccine. A system is used for generating antibodies without the use of any conventional adjuvant. The system comprises two or more different antigens and one or more lipid anchor. The key of this system is a novel carrier construct, which is non-toxic and non-immunogenic. The system contains variables, which allow optimising its structural configuration. A small library of poly-functional MALAC system will be synthesised in a controlled step-by-step way combining solution or solid phase techniques, where the exact chemical structure (and the order of the different immunological peptide sequences) of the construct is pre-determined. The antigenicity and the protection against disease will be compared with antigenicity and protection generated using conventional vaccine carriers. We also aim to exploit the particulate-forming properties of the lipo-peptide amphiphiles, to form micro-particulate oral antigens, exploiting the phenomenon of particulate uptake from the GI tract by the GALT or other intestinal sites. The MALAC constructs will be administered orally followed by the measurement of the serum IgG. Vaccination via the oral route is highly desirable, since it can overcome many of the disadvantages inherent in administration by injection - e.g. poor patient acceptability, requirement of skilled medical personnel, risk of HIV and other blood-born diseases, restricted availability and sometimes, stimulation of the wrong type of immunity. Development of vaccines for oral administration make them much more widely available, permitting self-administration and improving the operation of Public-Health vaccination programs, particularly in developing countries.Read moreRead less
A Novel Lipidic Adjuvant Carrier System For Vaccination Including Vaccination Via The Oral Route
Funder
National Health and Medical Research Council
Funding Amount
$214,593.00
Summary
We have developed a Lipid-Core-Peptide vaccine adjuvant system, based on the incorporation of lipoamino acids into poly-functional moiety that provides an excellent means for enhancing the antigenicity of a potential peptide-vaccine. As the system contains many variables, which allow substantial modifications to be made, we now wish to fully optimise its structural configuration. A library of spacer-lipoamino acid-poly-functional multiplier systems will be synthesised on solid phase. Model pepti ....We have developed a Lipid-Core-Peptide vaccine adjuvant system, based on the incorporation of lipoamino acids into poly-functional moiety that provides an excellent means for enhancing the antigenicity of a potential peptide-vaccine. As the system contains many variables, which allow substantial modifications to be made, we now wish to fully optimise its structural configuration. A library of spacer-lipoamino acid-poly-functional multiplier systems will be synthesised on solid phase. Model peptide epitopes will be synthesised on these different lipid-core systems and the antibody response will be compared with the response of the model peptide epitopes coupled to conventional vaccine carriers. The Lipid-Core Immunogen constructs including particulate systems will be administered orally as well, followed by measurement of the serum IgG response and the secretory IgA. This novel system can be used for any potential vaccine-peptide epitope and can open a new route to modern vaccination. The specific advantages of these kind of synthetic vaccines include the greater stability of the vaccine, reproducibility, eliminate the use of toxic conventional adjuvants. The key to this system is a novel carrier construct, which is non-toxic and not immunogenic. The system confers immunity with smaller risk of reaction, since it generates antibody production only against the infective microorganism. Vaccination via the oral route is highly desirable since it can overcome many of the disadvantages inherent in administration by injection - e.g. poor patient acceptability, requirement for skilled medical personnel, risk of HIV and other blood-borne diseases, restricted availability and, in cases, stimulation of the wrong type of immunity. Development of vaccines for oral administration will make them much more widely available, permitting self-administration by patients and markedly improving the operation of Public Health vaccination programs, particularly in developing countries.Read moreRead less
Effects Of N-3 Polyunsaturated Fatty Acids On Post Surgical Atrial Fibrillation: A Prospective Randomised Study
Funder
National Health and Medical Research Council
Funding Amount
$536,529.00
Summary
Consumption of fish and fish oil has been associated with protective effects for deaths from heart disease in many studies. The effects are consistent and quite strong and appear to be unrelated to blood cholesterol levels. The effects are more likely due to the possibility that fish oil, which contains n-3 fats, can suppress abnormal heart rhythms which can cause 'sudden cardiac death'. This has been shown in animal studies, and recently we have shown that they can also suppress abnormal heart ....Consumption of fish and fish oil has been associated with protective effects for deaths from heart disease in many studies. The effects are consistent and quite strong and appear to be unrelated to blood cholesterol levels. The effects are more likely due to the possibility that fish oil, which contains n-3 fats, can suppress abnormal heart rhythms which can cause 'sudden cardiac death'. This has been shown in animal studies, and recently we have shown that they can also suppress abnormal heart rhythms in humans. Patients undergoing coronary bypass surgery are particularly susceptible to abnormal heart rhythms in the upper chambers of the heart in the days immediately following surgery. While these abnormal rhythms are rarely life threatening, they can result in increased post-surgical complications and a longer hospital stay with associated increased costs to the health system. In this study we will determine whether providing high dose fish oil for 3 weeks immediately preceding coronary bypass surgery, will result in a reduction in the proportion of patients experiencing post-surgical abnormal heart rhythms. We will also examine the effects of n-3 fats on the incidence of other complications following bypass surgery and also the length of hospital stay. In addition, we will gather data which will provide insight into the mechanisms by which n-3 fatty acids produce their well documented benefits to patients with cardiovascular disease. The significance of this study is its ability to provide a protective strategy in heart disease in which the mechanism is understood, which is effective, and importantly, which will have the potential to provide savings to the health care system through a reduction in hospital stay.Read moreRead less
Does N-3 LCPUFA Supplementation In Pregnancy Reduce Asthma And Allergies In School Age Children?
Funder
National Health and Medical Research Council
Funding Amount
$443,833.00
Summary
We will determine whether supplementing the diets of pregnant women with fish oil can have long term effects on the development of the childÍs immune system and reduce the prevalence of asthma and allergies at early school age. The outcomes of our project will inform nutritional guidelines for pregnant women and, if successful, has the potential to significantly lower the costly burden of childhood asthma and allergies to families and the healthcare system.
N-3 LCPUFA Supplementation In Pregnancy To Reduce Allergies In Early Childhood
Funder
National Health and Medical Research Council
Funding Amount
$813,423.00
Summary
Over the last 20 years there has been a dramatic increase in allergic diseases in Australia as well as many other industrialised countries. This may be due to changes in our environment or diet. Over this period of time there has also been an increase in the dietary intake of n-6 fatty acids from vegetable oils and a corresponding decline in the intake of n-3 fatty acids from fish. Studies now indicate that there is a plausible link between these dietary changes and allergic diseases. Furthermor ....Over the last 20 years there has been a dramatic increase in allergic diseases in Australia as well as many other industrialised countries. This may be due to changes in our environment or diet. Over this period of time there has also been an increase in the dietary intake of n-6 fatty acids from vegetable oils and a corresponding decline in the intake of n-3 fatty acids from fish. Studies now indicate that there is a plausible link between these dietary changes and allergic diseases. Furthermore, emerging data suggest that the potential benefits of increasing n-3 fatty acids may be greatest during pregnancy and before allergic responses are established. Our project aims to minimise allergies in children from families where at least one parent has an allergy. We will assess whether dietary n-3 fatty acid supplementation of pregnant women will result in fewer children with allergies at 1 and 3 years of age. If the proposed intervention is successful, it would be a safe, cheap, acceptable and effective strategy to prevent allergies in children at high risk.Read moreRead less
Improving The Outcomes Of Mothers And Babies Through Nutritional Interventions
Funder
National Health and Medical Research Council
Funding Amount
$763,409.00
Summary
Dr Makrides will undertake extensive investigations to determine optimal levels of a range of nutrients in the diet of pregnant women and preterm and term babies. The period from conception until 2 years after birth, the ‘first 1,000 days’, is designated by the World Health Organisation as the “window of opportunity” that is critical to ensuring a healthy start to life which in turn leads to improved long term health of the population.
Docosahexaenic Acid (DHA) From Dairy. How Dietary Omega-3 Fats From Dairy Can Increase DHA Levels To Improve
Funder
National Health and Medical Research Council
Funding Amount
$427,887.00
Summary
A high level of the omega-3 fat DHA in the blood is related to good health and has benefits on neural development in breastfed infants. Infant formulas have been enriched with preformed DHA but are expensive and may be environmentally unsustainable. Dairy contains DPA, a direct precursor of DHA. I aim to identify DPA-rich dairy sources, produce a safe and inexpensive nutritional powder and validate its efficacy in an animal model and a human infant clinical trial. Based on research outcomes, thi ....A high level of the omega-3 fat DHA in the blood is related to good health and has benefits on neural development in breastfed infants. Infant formulas have been enriched with preformed DHA but are expensive and may be environmentally unsustainable. Dairy contains DPA, a direct precursor of DHA. I aim to identify DPA-rich dairy sources, produce a safe and inexpensive nutritional powder and validate its efficacy in an animal model and a human infant clinical trial. Based on research outcomes, this powder will be safe and inexpensive and have the potential to be marketed as a Infant Formula Supplement.Read moreRead less
Omega 3 Fats To Reduce The Incidence Of Prematurity: The ORIP Trial
Funder
National Health and Medical Research Council
Funding Amount
$2,705,590.00
Summary
The most significant perinatal problem in the world today is early preterm birth with its consequent threat to life and life-long health in survivors. Fish oils have been suggested to overcome this problem. Encouraging results have been obtained from small trials that need substantiation in a large well designed trial. The ORIP trial, involving approximately 5510 women, will provide a definitive answer to the question of whether maternal fish oils supplementation reduces early preterm birth.
Does N-3 LCPUFA Supplementation During Pregnancy Improve The Intelligence Quotient Of Children At School Age?
Funder
National Health and Medical Research Council
Funding Amount
$566,920.00
Summary
Pregnant women in Australia are being inundated by advertisements from health food companies and health organisations to increase their intake of fish oil to ensure that their babies will maximise their chance of achieving a high IQ. Our study will provide the first solid evidence to test whether these claims are true. This will help us frame nutritional guidelines in pregnant women.